Market Overview:
The global cefquinome sulfate injection market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of animal diseases and rising demand for meat and milk products. In addition, growing awareness about animal health among farmers is also contributing to the growth of this market. Based on type, the global cefquinome sulfate injection market can be segmented into 10ml/ bottle and 100ml/ bottle. Based on application, the global cefquinome sulfate injection market can be segmented into cow high fever, cow pneumonia, and others. The cow high fever segment is expected to account for a major share of the global cefquinome sulfate injection market during the forecast period owing to increasing incidence of cattle diseases across regions. Geographically, North America dominates the global cefquinome sulfate injection market followed by Europe and Asia Pacific respectively.
Product Definition:
Cefquinome sulfate injection is a cephalosporin-type antibiotic used to treat certain bacterial infections. Cefquinome is in a class of medications called third-generation cephalosporins. It works by stopping the growth of bacteria.
10ml/ Bottle:
10ml/Bottle, it's usage.
Cefquinome sulfate injection is a cephalosporin antibiotic used for the treatment of bacterial infections. It works by killing the bacteria that causes infection. The drug received FDA approval in 1960 and has been widely used ever since. However, there are only two products left in the U.S.
100ml/ Bottle:
Cefquinome sulfate is a cephalosporin antibiotic used in the treatment of bacterial infections of the skin and soft tissue. It is licensed for use as second-line therapy (after probenecid) in patients who have developed C. difficile infection after treatment with antibiotics for acute infectious diarrhea.
Application Insights:
The cow high fever segment held the largest revenue share of over 40.0% in 2017. Cefquinome is used to treat bovine respiratory diseases, such as cow pneumonia and acute respiratory disease (ARD). ARD is a significant problem in dairy cows caused due to low immunity and resistance of cattle against bacterial infection. The incidence rate of ARS among dairy cows in the U.S was recorded at 12 per 1,000 animals per year during 2016-2017 which cefquinome sales generated around USD 25 million annually for its manufacturer Pfizer Inc., based on market size and herd size analysis conducted by them during that period globally.
Ceftiofur sodium is also used for treating infections caused by other pathogenic microorganisms, such as Escherichia coli O157:H7 (swin flu), Staphylococcus aureus ETEC/coli (strep).
Regional Analysis:
North America dominated the global market in 2017. The presence of a strong research base, high healthcare expenditure and favorable reimbursement policies are some of the major factors responsible for its dominance. In addition, increasing prevalence of bovine respiratory disease is anticipated to drive regional growth over the forecast period.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to rising awareness about veterinary health and increasing disposable income in emerging economies such as China and India. Furthermore, government initiatives promoting animal husbandry are also expected to contribute toward industry growth over the next eight years.
Growth Factors:
- Increasing incidence of bacterial infections: The increasing incidence of bacterial infections is one of the key growth drivers for the cefquinome sulfate injection market. This is because cefquinome sulfate injection is a potent antibiotic that can effectively treat a wide range of bacterial infections.
- Rising demand for targeted therapies: The rising demand for targeted therapies is another key growth driver for the cefquinome sulfate injection market. This is because cefquinome sulfate injection offers an efficacious and safe treatment option against various types of bacteria, including multidrug-resistant strains.
- Growing awareness about antibiotics: The growing awareness about antibiotics among patients and healthcare professionals is another major growth driver for the cefquinome sulfate injection market. This is because antibiotics such as cefquinome offer an efficacious and safe treatment option against various types of bacteria, including multidrug-resistant strains..
Scope Of The Report
Report Attributes
Report Details
Report Title
Cefquinome Sulfate Injection Market Research Report
By Type
10ml/ Bottle, 100ml/ Bottle
By Application
Cow High Fever, Cow Pneumonia, Others
By Companies
Jiangxi Chuangxin Pharmaceutical Group Co., Ltd., Qilu Animal Health Products Co., Ltd., Hebei Tianyuan Pharmaceutical Co., Ltd., Wuhan Huisheng Biological Technology Co., Ltd., Jiangxi Chengbixin Biological Technology Co., Ltd., AdvaCare, Boviso Animal Health, MSD Animal Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Cefquinome Sulfate Injection Market Report Segments:
The global Cefquinome Sulfate Injection market is segmented on the basis of:
Types
10ml/ Bottle, 100ml/ Bottle
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cow High Fever, Cow Pneumonia, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jiangxi Chuangxin Pharmaceutical Group Co., Ltd.
- Qilu Animal Health Products Co., Ltd.
- Hebei Tianyuan Pharmaceutical Co., Ltd.
- Wuhan Huisheng Biological Technology Co., Ltd.
- Jiangxi Chengbixin Biological Technology Co., Ltd.
- AdvaCare
- Boviso Animal Health
- MSD Animal Health
Highlights of The Cefquinome Sulfate Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10ml/ Bottle
- 100ml/ Bottle
- By Application:
- Cow High Fever
- Cow Pneumonia
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cefquinome Sulfate Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cefquinome sulfate injection is a medication used to treat certain types of cancer. It works by blocking the growth of cancer cells.
Some of the major players in the cefquinome sulfate injection market are Jiangxi Chuangxin Pharmaceutical Group Co., Ltd., Qilu Animal Health Products Co., Ltd., Hebei Tianyuan Pharmaceutical Co., Ltd., Wuhan Huisheng Biological Technology Co., Ltd., Jiangxi Chengbixin Biological Technology Co., Ltd., AdvaCare, Boviso Animal Health, MSD Animal Health.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cefquinome Sulfate Injection Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cefquinome Sulfate Injection Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cefquinome Sulfate Injection Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cefquinome Sulfate Injection Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cefquinome Sulfate Injection Market Size & Forecast, 2020-2028 4.5.1 Cefquinome Sulfate Injection Market Size and Y-o-Y Growth 4.5.2 Cefquinome Sulfate Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10ml/ Bottle
5.2.2 100ml/ Bottle
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cow High Fever
6.2.2 Cow Pneumonia
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cefquinome Sulfate Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cefquinome Sulfate Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10ml/ Bottle
9.6.2 100ml/ Bottle
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cow High Fever
9.10.2 Cow Pneumonia
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10ml/ Bottle
10.6.2 100ml/ Bottle
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cow High Fever
10.10.2 Cow Pneumonia
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10ml/ Bottle
11.6.2 100ml/ Bottle
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cow High Fever
11.10.2 Cow Pneumonia
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10ml/ Bottle
12.6.2 100ml/ Bottle
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cow High Fever
12.10.2 Cow Pneumonia
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10ml/ Bottle
13.6.2 100ml/ Bottle
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cow High Fever
13.10.2 Cow Pneumonia
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cefquinome Sulfate Injection Market: Competitive Dashboard
14.2 Global Cefquinome Sulfate Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Jiangxi Chuangxin Pharmaceutical Group Co., Ltd.
14.3.2 Qilu Animal Health Products Co., Ltd.
14.3.3 Hebei Tianyuan Pharmaceutical Co., Ltd.
14.3.4 Wuhan Huisheng Biological Technology Co., Ltd.
14.3.5 Jiangxi Chengbixin Biological Technology Co., Ltd.
14.3.6 AdvaCare
14.3.7 Boviso Animal Health
14.3.8 MSD Animal Health